LONDON, September 23 /PRNewswire/ -- FindAdBlue.com (http://www.findadblue.com/) is pleased to announce that it will be exhibiting at the 62nd IAA Commercial Vehicles in Hannover from 25 September to 2 October 2008. The FindAdBlue.com stand will provide visitors to the show with information about diesel SCR technology and AdBlue, maps showing AdBlue availability in Europe, and advice on the ways to buy and use AdBlue. The FindAdBlue.com stand will be located in Hall 18, at A25. The sponsors of FindAdBlue.com at the 62nd IAA Commercial Vehicles are Mercedes-Benz, Renault Truck Company, Scania and Yara Air1.

MUMBAI, India, September 23 /PRNewswire/ -- Sun Pharmaceutical Industries Ltd. announced that USFDA has granted an approval for the Abbreviated New Drug Application (ANDA) to market generic Paraplatin (R), carboplatin injection.

These generic versions of carboplatin 10mg/ml injections packed in 5 ml, 15ml and 45 ml single use vials are bio-equivalent to Paraplatin (R) injections distributed by Bristol Myers Squibb Oncology/Virology.

Carboplatin injections are indicated as initial and secondary therapy in patients with advanced ovarian carcinoma.

These strengths of Paraplatin(R) Injections have annual sales of approximately USD 45 million in the US.

Paraplatin (R) is a registered trademark of Bristol Myers Squibb Company.

LONDON, September 23 /PRNewswire/ -- Enecto offers new opportunities for B2B advertisers to target and reach visitors from certain companies with specific ads. This enables B2B advertisers to dramatically improve their digital marketing effectiveness.

Enecto, one of the leading companies in Europe within marketing and sales solutions for business-to-business (B2B) companies with a web presence, is now launching a B2B targeting solution for digital marketing.

Enecto owns a proprietary database with information about companies' IP numbers as well as detailed information about the companies like number of employees, industry, turnover and geographical location. All of this information can be used for B2B targeting.

MENLO PARK, California, September 23 /PRNewswire/ --

- European Physicians Show Strong Interest in MitraClip System

Evalve, Inc., the leader in the development of devices for the percutaneous repair of cardiac valves, announced today that the first two patients have been treated with its MitraClip(R) system in Hamburg, Germany. The MitraClip system is the first commercially available device which enables a non-surgical option for patients suffering from the effects of mitral regurgitation (MR).

TORONTO, September 23 /PRNewswire/ -- Apotex Inc, the largest Canadian-owned pharmaceutical company, is pleased to announce that Apo-TriAvir, a triple combination HIV/AIDS drug, approved under Canada's Access to Medicines Regime (CAMR), is ready to ship to Rwanda, the only country to make a request through a program tender process. The first shipment of seven million tablets, which will help save the lives of 21,000 people, is scheduled to leave from Toronto on September 24th, 2008. Apotex is doing this on a humanitarian, not-for-profit basis.

COLLEGEVILLE, Pennsylvania, September 23 /PRNewswire/ --

- 85,000 Expected to Enroll in Phase 4 Study Initiated Pre-Registration -

Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), today announced the initiation of the Community Acquired Pneumonia Immunization Trial in Adults a major study in adults of an investigational 13-valent conjugate vaccine designed to help prevent pneumococcal pneumonia -- the leading cause of bacterial pneumonia in adults.

In Europe and the United States, pneumococcal pneumonia is the most common community-acquired bacterial pneumonia, for which the adult mortality rate averages between 10 to 20 percent. That rate may exceed 50 percent in high-risk groups worldwide.